|
| Adalimumab n (%) | Etarnercept n (%) | Rituximab n (%) |
| 6 Months Good EULAR Response DAS 28 ≤ 3.2 | 13 (48.1) | 10 (47.6) | 8 (22.9) |
| Moderate EULAR Response DAS 28 > 3.2 and ≤ 5.1 | 7 (25.9) | 8 (38.1) | 11 (31.4) |
| No EULAR Response DAS 28 > 5.1 | 7 (25.9) | 3 (14.3) | 16 (45.7) |
| 12 Months Good EULAR Response DAS 28 ≤ 3.2 | 6 (28.5) | 7 (46.6) | 9 (36.0) |
| Moderate EULAR Response DAS 28 > 3.2 and ≤ 5.1 | 7 (33.3) | 6 (40.0) | 9 (36.0) |
| No EULAR Response DAS 28 > 5.1 | 8 (38.1) | 2 (13.3) | 7 (28.0) |